96 related articles for article (PubMed ID: 9926236)
1. Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
Franklin J; Tesch H; Hansmann ML; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S39-44. PubMed ID: 9926236
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte predominant Hodgkin's disease.
Ekstrand BC; Horning SJ
Curr Oncol Rep; 2002 Sep; 4(5):424-33. PubMed ID: 12162918
[TBL] [Abstract][Full Text] [Related]
8. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
[TBL] [Abstract][Full Text] [Related]
9. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
Grossman DM; Hanson CA; Schnitzer B
Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte predominant Hodgkin's disease: clinical presentation and results of treatment.
Russell KJ; Hoppe RT; Colby TV; Burns BF; Cox RS; Kaplan HS
Radiother Oncol; 1984 Jan; 1(3):197-205. PubMed ID: 6505256
[TBL] [Abstract][Full Text] [Related]
12. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
13. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
Regula DP; Weiss LM; Warnke RA; Dorfman RF
Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
[TBL] [Abstract][Full Text] [Related]
15. [Hodgkin's disease: a mystery is being solved].
Stein H; Hummel M; Marafioti T; Korbjuhn P; Anagnostopoulos I; Foss HD
Verh Dtsch Ges Pathol; 1997; 81():327-38. PubMed ID: 9474887
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
17. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.
Hedvat CV; Jaffe ES; Qin J; Filippa DA; Cordon-Cardo C; Tosato G; Nimer SD; Teruya-Feldstein J
Mod Pathol; 2001 Dec; 14(12):1270-6. PubMed ID: 11743050
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
Ohsawa M; Aozasa K; Ikeda H
Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
[TBL] [Abstract][Full Text] [Related]
20. Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease.
Tefferi A; Wiltsie JC; Kurtin PJ
Am J Hematol; 1992 Jul; 40(3):232-3. PubMed ID: 1609779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
